Back to ANRO
WELLINGTON MANAGEMENT GROUP LLP → ANRO
WELLINGTON MANAGEMENT GROUP LLP ANRO Position History
Alto Neuroscience, Inc. • Healthcare
Quarters held
12
Latest value
$1.4M
Q3 2026
Peak value
$1.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $350K |
| Q4 2025 | $55K |
| Q4 2025 | $823K |
| Q1 2026 | $412K |
| Q1 2026 | $64K |
| Q1 2026 | $869K |
| Q2 2026 | $593K |
| Q2 2026 | $81K |
| Q2 2026 | $1.2M |
| Q3 2026 | $832K |
| Q3 2026 | $133K |
| Q3 2026 | $1.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.4M | 53.9K | — | — |
| Q3 2026 | $133K | 5.2K | — | — |
| Q3 2026 | $832K | 32.6K | — | — |
| Q2 2026 | $1.2M | 45.4K | — | — |
| Q2 2026 | $81K | 3.1K | — | — |
| Q2 2026 | $593K | 22.5K | — | — |
| Q1 2026 | $869K | 38.7K | — | — |
| Q1 2026 | $64K | 2.8K | — | — |
| Q1 2026 | $412K | 18.3K | — | — |
| Q4 2025 | $823K | 46.2K | — | — |
| Q4 2025 | $55K | 3.1K | — | — |
| Q4 2025 | $350K | 19.7K | — | — |
Other funds holding ANRO
$97.8M
$94.7M
$83.4M
$71.9M
$69.5M
$61.2M